Inventor · disambiguated record
Steven Kazmirski
Also filed as: KAZMIRSKI STEVEN
7 granted patents·1 pending application·16 citations·filing 2017–2024
80Inventor score
Top patents by PatentIndex Score
8 records- 0194US10973805B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 13, 2021·5 cites·20 claims
- 0291US11590111B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·10 claims
- 0389US9840518B2MCL-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2017·Granted Dec 12, 2017·9 cites·4 claims
- 0483US2025195480A1Macrocyclic azolopyridine derivatives as eed and prc2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0581US12109198B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·5 claims
- 0669US11472816B2Mcl-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Granted Oct 18, 2022·0 cites·9 claims
- 0767US10889594B2MCL-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2018·Granted Jan 12, 2021·0 cites·10 claims
- 0859US10196404B2MCL-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2017·Granted Feb 5, 2019·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Steven Kazmirski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →